SLC6A3 and Huntington disease: Sodium-dependent dopamine transporter (Slc6a3) knockout mice exhibited two activity components (~23.5 h and ~27 h) in DD without methamphetamine.17 R6/2 Huntington’s disease model mice have compromised dopamine signalling and MASCO-driven activity rhythms.